Treating sepsis with a medication plus blood thinner
Part of Infections clinical trials.
This trial studies whether combining anisodamine (a medicine for certain gut/smooth-muscle effects) with a low-molecular-weight blood thinner helps treat sepsis. It may be aimed at improving outcomes compared with standard care, but eligibility depends on safety factors like bleeding risk and organ function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be over 18 years old.
- You must meet the study’s sepsis diagnosis criteria (Sepsis-3).
- You (or a legal representative) must be able to agree to participate and sign consent.
- You should not be expected to die within 24 hours after starting the study.
- You must not have a known reason you cannot safely take the blood thinner or anisodamine (scopolamine butylbromide).
- You must not be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medicine called anisodamine can improve blood flow in tiny vessels (microcirculation) under your tongue and help stabilize blood pressure in patients with septic shock. It may offer a new way to support recovery in the ICU.
This study tests a new drug (BAY 3389934) for people with sepsis who also have a blood clotting problem. It aims to find the right dose and make sure the drug is safe.
This trial tests if the oral medication midodrine can help wean patients with sepsis off IV vasopressors faster, potentially reducing ICU stays and complications.
This trial looks at whether a blood-filter treatment (called “AN69ST Verse PS” using a hemofilter) can help children with early, serious sepsis and poor circulation or organ problems. It may help stabilize the body faster, but eligibility is limited to certain sepsis situations and recent timing.
This trial tests if a special fluid given through a vein can protect and repair the lining of your blood vessels during sepsis. Sepsis is a dangerous reaction to an infection that can damage organs. This study aims to see if this treatment helps patients in the intensive care unit (ICU) recover better.
This trial tests a special way to monitor tiny blood vessels (microcirculation) in patients with sepsis. The goal is to see if early treatment based on these readings can help improve recovery.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.